Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

PLGA based film forming systems for superficial fungal infections treatment

E. Šnejdrová, J. Martiška, J. Loskot, G. Paraskevopoulos, A. Kováčik, G. Regdon, M. Budai-Szűcs, K. Palát, K. Konečná

. 2021 ; 163 (-) : 105855. [pub] 20210416

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018381

As proven in clinical trials, superficial fungal infections can be effectively treated by single topical application of terbinafine hydrochloride (Ter-HCl) in a film forming system (FFS). Poly(lactic-co-glycolic acid) (PLGA) derivatives, originally synthesized with intention to get carriers with optimized properties for drug delivery, and multifunctional plasticizers - ethyl pyruvate, methyl salicylate, or triacetin - were used for formulation of Ter-HCl loaded FFSs. After spraying, a biodegradable, transparent, adhesive, and occlusive thin layer is formed on the skin, representing drug depot. In situ formed films were characterized by thermal, structural, viscoelastic, and antifungal properties as well as drug release and skin penetration. DSC and SEM showed fully amorphous films with Ter-HCl dissolved in PLGA in high concentration (up to 15%). FFSs are viscoelastic fluids with viscosity which can be easily adjusted by the type of plasticizer used and its concentration. The formulations showed excellent bioadhesion properties, thus ensuring persistence on the skin. In situ film based on branched PLGA/A plasticized with 10% of ethyl pyruvate allowed prolonged release of Ter-HCl by linear kinetics for the first 6 days with a total time of almost 14 days. During ex vivo human skin penetration experiment, Ter-HCl was found to be located only in its target layer, the epidermis. According to our results, plasticized branched PLGA derivatives loaded by Ter-HCl are suitable for the development of FFSs for superficial fungal infections treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018381
003      
CZ-PrNML
005      
20210830095950.0
007      
ta
008      
210728s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2021.105855 $2 doi
035    __
$a (PubMed)33872699
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Šnejdrová, Eva $u Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
245    10
$a PLGA based film forming systems for superficial fungal infections treatment / $c E. Šnejdrová, J. Martiška, J. Loskot, G. Paraskevopoulos, A. Kováčik, G. Regdon, M. Budai-Szűcs, K. Palát, K. Konečná
520    9_
$a As proven in clinical trials, superficial fungal infections can be effectively treated by single topical application of terbinafine hydrochloride (Ter-HCl) in a film forming system (FFS). Poly(lactic-co-glycolic acid) (PLGA) derivatives, originally synthesized with intention to get carriers with optimized properties for drug delivery, and multifunctional plasticizers - ethyl pyruvate, methyl salicylate, or triacetin - were used for formulation of Ter-HCl loaded FFSs. After spraying, a biodegradable, transparent, adhesive, and occlusive thin layer is formed on the skin, representing drug depot. In situ formed films were characterized by thermal, structural, viscoelastic, and antifungal properties as well as drug release and skin penetration. DSC and SEM showed fully amorphous films with Ter-HCl dissolved in PLGA in high concentration (up to 15%). FFSs are viscoelastic fluids with viscosity which can be easily adjusted by the type of plasticizer used and its concentration. The formulations showed excellent bioadhesion properties, thus ensuring persistence on the skin. In situ film based on branched PLGA/A plasticized with 10% of ethyl pyruvate allowed prolonged release of Ter-HCl by linear kinetics for the first 6 days with a total time of almost 14 days. During ex vivo human skin penetration experiment, Ter-HCl was found to be located only in its target layer, the epidermis. According to our results, plasticized branched PLGA derivatives loaded by Ter-HCl are suitable for the development of FFSs for superficial fungal infections treatment.
650    _2
$a antifungální látky $7 D000935
650    12
$a nosiče léků $7 D004337
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a lidé $7 D006801
650    12
$a mykózy $7 D009181
650    _2
$a terbinafin $7 D000077291
655    _2
$a časopisecké články $7 D016428
700    1_
$a Martiška, Juraj $u Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic; InStar Technologies a.s., Mrstikova 399/2a, 460 07 Liberec, Czech Republic. Electronic address: martiska@instar.tech
700    1_
$a Loskot, Jan $u Department of Physics, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, Hradec Kralove 500 03, Czech Republic
700    1_
$a Paraskevopoulos, Georgios $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
700    1_
$a Kováčik, Andrej $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
700    1_
$a Regdon, Géza $u Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
700    1_
$a Budai-Szűcs, Mária $u Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
700    1_
$a Palát, Karel $u Department of Organic And Bioorganic Chemistry, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
700    1_
$a Konečná, Klára $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 163, č. - (2021), s. 105855
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33872699 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830095951 $b ABA008
999    __
$a ok $b bmc $g 1689492 $s 1138825
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 163 $c - $d 105855 $e 20210416 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...